Reactive arthritis: Difference between revisions

No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Historically also known as "Reiter syndrome"
*Seronegative spondyloarthropathy that manifests as an acute, asymmetric, oligoarthritis (LE>UE) that occurs 2-6 weeks after infection
*Seronegative spondyloarthropathy that manifests as an acute, asymmetric, oligoarthritis (LE>UE) that occurs 2-6 weeks after infection
*Patients often positive for HLA-B27
*Associated with bacterial infections
*Associated with bacterial infections
**Shigella, Salmonella, Campylobacter, Chlamydia, etc.
**[[Shigella]], [[Salmonella]], [[Campylobacter]], [[Chlamydia]], etc.
*Classic triad: urethritis, conjunctivitis, and arthritis ("Can't pee, can't see, can't climb a tree")
*Classic triad: [[urethritis]], [[conjunctivitis]], and [[arthritis]] ("Can't pee, can't see, can't climb a tree")


==Clinical Features==
==Clinical Features==
Line 9: Line 11:
**[[Urethritis]]: generally caused by Chlamydia or Ureaplasma
**[[Urethritis]]: generally caused by Chlamydia or Ureaplasma
**Enteritis: generally caused by Salmonella or Shigella
**Enteritis: generally caused by Salmonella or Shigella
**Respiratory tract infections, both bacterial and viral (case reports have been written about COVID-19 associated reactive arthritis)
**Preceding infection may be clinically silent
**Preceding infection may be clinically silent
*Musculoskeletal symptoms
*Musculoskeletal symptoms
Line 15: Line 18:
**[[Dactylitis]] (sausage digits)
**[[Dactylitis]] (sausage digits)
**[[Low back pain]]
**[[Low back pain]]
*Extraarticular symptoms
*Extra-articular symptoms
**[[Conjunctivitis]] (less frequently [[uveitis]], [[keratitis]])
**[[Conjunctivitis]] (less frequently [[uveitis]], [[keratitis]])
**GU symptoms
**GU symptoms
Line 35: Line 38:
==Evaluation==
==Evaluation==
*Clinical diagnosis
*Clinical diagnosis
*Must exclude [[Gonococcal septic arthritis|gonococcal arthritis]] and other mimics
*Must exclude [[Gonococcal arthritis|gonococcal arthritis]] and other mimics


==Management==
==Management==
Line 41: Line 44:
*Symptomatic treatment of arthritis
*Symptomatic treatment of arthritis
**[[NSAIDs]] are first line ([[naproxen]], [[diclofenac]], [[indomethacin]])
**[[NSAIDs]] are first line ([[naproxen]], [[diclofenac]], [[indomethacin]])
**Intraarticular and systemic steroids for NSAID refractory
**Intraarticular and systemic [[steroids]] for NSAID refractory


==Disposition==
==Disposition==

Latest revision as of 00:31, 13 August 2021

Background

  • Historically also known as "Reiter syndrome"
  • Seronegative spondyloarthropathy that manifests as an acute, asymmetric, oligoarthritis (LE>UE) that occurs 2-6 weeks after infection
  • Patients often positive for HLA-B27
  • Associated with bacterial infections
  • Classic triad: urethritis, conjunctivitis, and arthritis ("Can't pee, can't see, can't climb a tree")

Clinical Features

  • Preceding Infection
    • Urethritis: generally caused by Chlamydia or Ureaplasma
    • Enteritis: generally caused by Salmonella or Shigella
    • Respiratory tract infections, both bacterial and viral (case reports have been written about COVID-19 associated reactive arthritis)
    • Preceding infection may be clinically silent
  • Musculoskeletal symptoms
  • Extra-articular symptoms
  • Keratoderma blennorrhagicum[1]
    • Develops in 15% of patients
    • Found on palm/soles. Vesicles/pustules with yellow/brown color. Appears similar to pustular psoriasis

Differential Diagnosis

Monoarticular arthritis

Algorithm for Monoarticular arthralgia

Oligoarthritis

Polyarthritis

Algorithm for Polyarticular arthralgia

Migratory Arthritis

Evaluation

Management

Disposition

  • Outpatient follow up, with DMARDs if refractory to NSAIDs
  • 70% self-limited disease

See Also

External Links

References

  1. Wolff K, Johnson R, Saavedra AP. The Skin in Immune, Autoimmune, and Rheumatic Disorders. In: Wolff K, Johnson R, Saavedra AP. eds. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, 7e. New York, NY: McGraw-Hill; 2013.